Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Urothelial Cancer
NCT00009867Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2000
- Primary completion
- Jun 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in urothelial carcinoma (UC), sponsored by National Cancer Institute. Started Dec 2000; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00009867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009867.